Maurer, M. S., Soman, P., Hernandez, A., Garcia-Pavia, P., Signorovitch, J., Wei, L. J., Hanna, M., Ruberg, F. L., Kittleson, M., Kazi, D., Dorbala, S., Hsu, K., Lousada, I., Adigun, R., Dunnmon, P., Kelly, J., Gillmore, J., Masri, A., … Sanjurjo, V. (2024). Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in Therapy, 41(7), 2723–2742. https://doi.org/10.1007/s12325-024-02891-0

Teles, D., & Fine, B. M. (2024). Using induced pluripotent stem cells for drug discovery in arrhythmias. Expert Opinion on Drug Discovery, 19(7), 827–840. https://doi.org/10.1080/17460441.2024.2360420

Loomba, R., Clark, G., Teckman, J., Ajmera, V., Behling, C., Brantly, M., Brenner, D., D’Armiento, J., Fried, M. W., Iyer, J. S., Mandorfer, M., Rockey, D. C., Tincopa, M., Vuppalanchi, R., Younossi, Z., Krag, A., Turner, A. M., & Strnad, P. (2024). Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease. Alimentary Pharmacology & Therapeutics, 59(10), 1183–1195. Portico. https://doi.org/10.1111/apt.17967